271. Ankylosing spondylitis Clinical trials / Disease details

Clinical trials : 563 / Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

36 trials found

diseases per page:

Showing 1 to 10 of 36 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-205414	12/12/2020	18/08/2020	A study to evaluate the long-term safety, tolerability and efficacy of bimekizumabin subjects with a ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Nonradiographic axial spondyloarthritis / Ankylosing spondylitis	Intervention name : UCB4940 INN of the intervention : bimekizumab Dosage And administration of the int ...	UCB Japan Co., Ltd.	NULL	recruiting	18		BOTH	30	Phase 3	Japan, Asia except Japan, North America, Europe
2	EUCTR2019-004163-47-GB (EUCTR)	08/10/2020	05/08/2020	A study to evaluate the long-term safety, tolerability and efficacy of bimekizumabin subjects with a ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	485	Phase 3	United States;Spain;Turkey;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;Bulgaria;Germ ...
3	EUCTR2019-004163-47-DE (EUCTR)	23/07/2020	27/04/2020	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	485	Phase 3	United States;Czechia;Spain;Turkey;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;Bulga ...
4	EUCTR2019-004163-47-HU (EUCTR)	16/06/2020	01/04/2020	A study to evaluate the long-term safety, tolerability and efficacy of bimekizumabin subjects with a ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	485	Phase 3	United States;Spain;Turkey;United Kingdom;France;Hungary;Czech Republic;Belgium;Poland;Bulgaria;Germ ...
5	NCT04436640 (ClinicalTrials.gov)	June 16, 2020	15/6/2020	A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumabin Subjects With A ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Axial Spondyloarthritis;Ankylosing Spondylitis;r-axSpa	Drug: Bimekizumab	UCB Biopharma SRL	NULL	Enrolling by invitation	18 Years	N/A	All	485	Phase 3	United States;Belgium;Bulgaria;China;Czechia;France;Germany;Hungary;Japan;Netherlands;Poland;Spain;T ...
6	EUCTR2019-004163-47-BG (EUCTR)	04/06/2020	14/05/2020	A study to evaluate the long-term safety, tolerability and efficacy of bimekizumabin subjects with a ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	485	Phase 3	Japan;China;Netherlands;Germany;Bulgaria;Poland;Belgium;Hungary;Czech Republic;France;United Kingdom ...
7	EUCTR2019-004163-47-CZ (EUCTR)	26/05/2020	07/04/2020	A study to evaluate the long-term safety, tolerability and efficacy of bimekizumabin subjects with a ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	485	Phase 3	United States;Spain;Turkey;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;Bulgaria;Germ ...
8	JPRN-JapicCTI-194860	30/9/2019	16/07/2019	A Study to Evaluate the Efficacy and Safety of Bimekizumabin Subjects With Active Ankylosing Spondyl ...	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy a ...	Ankylosing Spondylitis	Intervention name : UCB4940 INN of the intervention : bimekizumab Dosage And administration of the int ...	UCB Japan Co., Ltd	NULL	complete	18		BOTH	15	Phase 3	Japan, Asia except Japan, North America
9	EUCTR2017-003065-95-NL (EUCTR)	03/07/2019	25/07/2019	A study to evaluate the efficacy and safety ofbimekizumab in subjects with active ankylosingspondyli ...	A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THEEFFICACY AN ...	Ankylosing spondylitis MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylosing ...	Product Name: bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	United States;Czechia;Spain;Turkey;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;Bulga ...
10	EUCTR2017-003065-95-GB (EUCTR)	01/07/2019	29/03/2019	A study to evaluate the efficacy and safety of bimekizumabin subjects with active ankylosing spondyl ...	A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY A ...	Ankylosing spondylitis MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylosing ...	Product Name: bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	United States;Czechia;Spain;Turkey;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;Bulga ...

First Previous1 2 3 4Next Last